[The effect of UFT on lymphocyte subsets and lymphocyte response to PHA].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000276:immunology; D006801:Humans; D007121:Immunocompetence; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000145:classification* / Q000187:drug effects; D008875:Middle Aged; D010835:Phytohemagglutinins / Q000494:pharmacology; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000276:immunology*; D005641:Tegafur / Q000008:administration & dosage / Q000494:pharmacology; D014498:Uracil / Q000008:administration & dosage / Q000494:pharmacology
D010835:Phytohemagglutinins; D005641:Tegafur; D014498:Uracil